Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts: real-world safety and feasibility evidence

• N.A. Oberheim-Bush,
• W. Shi,
• M.W. McDermott,
• A. Grote,
• J. Stindl,
• L. Lustgarten

Affiliations

N.A. Oberheim-Bush

University of California, Division of Neuro-Oncology, San Francisco, United States

W. Shi

Thomas Jefferson University, Department of Radiation Oncology, Philadelphia, United States

M.W. McDermott

Miami Neuroscience Institute, Baptist Health South Florida, Division of Neurosurgery, Miami, United States

A. Grote

Clinic for Neurosurgery, University Hospital OWL, Evangelisches Klinikum Bethel, Bielefeld, Germany

J. Stindl

Novocure GmbH, Medical Safety, Munich, Germany

L. Lustgarten

Novocure Inc., New York, United States